Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.
Press releases published on June 24, 2025

Addressing Surging Demand, Vetty Reports Strong Growth, Strategic Wins and Expanded Integrations in 1H 2025
AUSTIN, Texas, June 24, 2025 (GLOBE NEWSWIRE) -- Seeing a 22.4 percent increase in revenue year over year, Vetty, the one-stop shop hiring acceleration platform, has continued to build on its momentum in the first half of 2025. On pace to surpass its June …

Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
Intra-patient, double-blind, multicenter, placebo-controlled study with crossover design Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significant …

Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure
TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen …

Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare …

Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced …

Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addicted Cancers
Flexible funding provides $2 billion in committed capital comprised of up to $1.25 billion of synthetic royalty and up to $750 million in corporate debt Company moving forward with independent global commercialization strategy to prioritize patient reach …

RentRedi Survey: Smaller Landlords 60% More Likely to Enforce Renters Insurance
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- A new joint survey from RentRedi, the fastest-growing landlord software that makes renting easy for everyone, and BiggerPockets, the largest online community for real estate investors, reveals that while most …

Castellum, Inc. Announces Creation of New Subsidiary to Focus on Advanced Technology Products
VIENNA, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company” and “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services and solutions company focused on the federal government, today announced the …

Walking Comfort Accelerates Ecommerce Growth with Descartes Sellercloud™
ATLANTA, June 24, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Utah-based Walking Comfort, a leading retailer in the local and online …

KIF18A Inhibitor Clinical Trials FDA Approved KIF18A Targeting Therapies Market Report
Delhi, June 24, 2025 (GLOBE NEWSWIRE) -- Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms …

KANZHUN LIMITED Announces Launch of Share Offer
BEIJING, June 24, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced the launch of its share offer of 30,000,000 Class A ordinary shares, …

Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Top-line trial results are anticipated in the third quarter of 2026, after the final follow-up at 12-months Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS anticipated in 2026, if ELPIS II results are …

Odoo Connect 2025 Storms Back to San Francisco This Fall, with Over 90 Speakers and More Than 100 Sessions
A Flagship Event for Open‑Source Business Innovation, Odoo Has Experienced 10X Growth in the Last 10 years SAN FRANCISCO, June 24, 2025 (GLOBE NEWSWIRE) -- Odoo, the leading provider of enterprise resource planning (ERP) and customer relationship …

Cribl Appoints Mike Kourey to its Board of Directors as Audit Committee Chair
SAN FRANCISCO, June 24, 2025 (GLOBE NEWSWIRE) -- Cribl, the Data Engine for IT and Security, today announced it has appointed Mike Kourey to its board of directors as audit committee chair. A recognized financial leader with a distinguished career spanning …

Nano Labs Announces US$500 Million Convertible Notes Private Placement for BNB Treasury Strategy
HONG KONG, June 24, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure and product solution provider in China, today announces that it has entered into a convertible notes purchase …

Zeelo Raises $23M Series B to Accelerate AI-Powered Transportation-as-a-Service Growth in North America, UK & Ireland
LONDON and BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Zeelo, the category-leading Transportation-as-a-Service (TaaS) provider for employers and schools offering mobility as a benefit, today announced the close of its $23 million Series B funding round. The …

Aurora Mobile’s Board of Directors Approves Investment in Digital Assets
SHENZHEN, China, June 24, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that its Board of Directors has …

Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas
Heat-triggered release mechanism unequivocally confirmed Favorable safety profile with good tolerability Signs of encouraging clinical activity in heavily pre-treated patients including meaningful progression-free survival (PFS) One participant with …

EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer
OSLO, Norway, June 24, 2025 (GLOBE NEWSWIRE) -- EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, is pleased to announce first patient dosed in its ENACT trial. The trial is a multi-centre, open-label Phase 2 clinical …

Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
For media and investors only Researchers identified variants which may cause activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Results enable clinical genetic testing labs to appropriately reclassify VUSs, accelerating the path to a …